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Background: The obligate intracellular parasite Toxoplasma gondii establishes a life-long chronic infection within
any warm-blooded host. After ingestion of an encysted parasite, T. gondii disseminates throughout the body as a
rapidly replicating form during acute infection. Over time and after stimulation of the host immune response, T. gondii
differentiates into a slow growing, cyst form that is the hallmark of chronic infection. Global transcriptome analysis of
both host and parasite during the establishment of chronic T. gondii infection has not yet been performed. Here, we
conducted a dual RNA-seq analysis of T. gondii and its rodent host to better understand host and parasite responses
during acute and chronic infection.
Results: We obtained nearly one billion paired-end RNA sequences from the forebrains of uninfected, acutely and
chronically infected mice, then aligned them to the genomic reference files of both T. gondii and Mus musculus. Gene
ontology (GO) analysis of the 100 most highly expressed T. gondii genes showed less than half were shared between
acute and chronic infection. The majority of the highly expressed genes common in both acute and chronic infection
were involved in transcription and translation, underscoring that parasites in both stages are actively synthesizing
proteins. Similarly, most of the T. gondii genes highly expressed during chronic infection were involved in metabolic
processes, again highlighting the activity of the cyst stage at 28 days post-infection. Comparative analyses of host
genes using uninfected forebrain revealed over twice as many immune regulatory genes were more abundant during
chronic infection compared to acute. This demonstrates the influence of parasite development on host gene
transcription as well as the influence of the host environment on parasite gene transcription.
Conclusions: RNA-seq is a valuable tool to simultaneously analyze host and microbe transcriptomes. Our data
shows that T. gondii is metabolically active and synthesizing proteins at 28 days post-infection and that a distinct
subset of host genes associated with the immune response are more abundant specifically during chronic infection.
These data suggest host and pathogen interplay is still present during chronic infection and provides novel T. gondii
targets for future drug and vaccine development.
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Toxoplasma gondii is an obligate intracellular parasite
that can infect any nucleated cell of warm-blooded ani-
mals. The parasite has both sexual and asexual cycles
where the sexual cycle takes place in the intestinal cells
of the definitive feline host and the asexual cycle occurs* Correspondence: ljknoll@wisc.edu
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unless otherwise stated.in all warm-blooded animals [1]. The asexual stages of
T. gondii consist of the rapidly replicating tachyzoite and
the slow growing encysted bradyzoite. In the host, the
tachyzoite is the prominent stage during initial acute in-
fection [2]. Once the tachyzoite is subjected to stress
from the host immune response, it differentiates to the
bradyzoite form and eventually establishes a chronic in-
fection [3]. The bradyzoite persists for the lifetime of the
host as intracellular cysts present in striated muscle and
the central nervous system [4].l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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humans with prevalence rates between 10 and 80 per-
cent worldwide, depending on the country [5]. Compli-
cations such as hydrocephaly, retinochoroiditis, mental
retardation and even death can occur in developing fe-
tuses [6,7]. In immunocompetent humans, infection with
T. gondii is generally asymptomatic presenting flu-like
symptoms in approximately 10 percent of individuals
[8]. Patients with compromised immune systems, such
as those infected with HIV, are at great risk of develop-
ing severe symptoms such as Toxoplasmic Encephalitis
(TE) and ocular infection that may result in blindness
[9,10]. Disease is largely associated with sporadic reacti-
vation of the latent bradyzoite back to the rapidly repli-
cating tachyzoite [11]. Currently there are no drugs that
can combat the bradyzoite form of the parasite or effect-
ive vaccines to protect against infection. These issues
highlight the critical need to understand the cellular
triggers that control development between the tachyzoite
and bradyzoite stages.
Previous work to characterize the transcriptome of
tachyzoite and bradyzoites from T. gondii has primarily
used microarray technology from samples prepared in
tissue culture [12-14]. Transcriptomic studies have also
used a combination of in vitro and in vivo samples with
in vitro tachyzoites, in vivo bradyzoites, and oocysts col-
lected from infected felines as well as tissue culture
tachyzoites and bradyzoites, developing oocysts, and bra-
dyzoites purified from mouse brains 21 days post-infection
[12,15] While these studies have provided valuable insight
into this developmental process, the information that can
be extracted is limited because tissue culture conditions for
tachyzoite and bradyzoite development do not precisely
model animal infections. Other in vivo microarray studies
have compared peritoneal-derived tachyzoites from differ-
ent strain types of T. gondii from wild type and interferon-
γ (IFN-γ) deleted mice, and transcriptional changes in the
brain of mice eight days after T. gondii infection [16-18].
These studies have highlighted important aspects of the
developmental process, but the dynamic range of microar-
rays is restricted and sample preparations are unable to be
simultaneously processed and analyzed for both host and
pathogen. One way to overcome these limitations is RNA
sequencing (RNA-seq), a breakthrough molecular tool that
can provide the transcript profile (transcriptome) of total
cellular RNA with a large dynamic range and improved
sensitivity [19]. RNA-seq has detected novel T. gondii
tachyzoite transcripts and alternative splicing between
strains [20]. RNA-seq of tissue culture-derived bradyzoites
has shown dysregulation of bradyzoite genes in the dele-
tion mutant of a mucin domain containing cyst wall pro-
tein CST1 [21]. Using RNA-seq, transcriptome analysis has
been performed to compare mouse brains that were unin-
fected or infected with T. gondii for 32 days [22]. Thesedata highlight the sensitivity and depth of knowledge that
can be obtained from RNA-seq studies; however, a time
course of T. gondii infection and simultaneous analysis of
the parasite transcriptome has not been performed.
To provide a more comprehensive analysis of T. gondii
and the host during both acute and chronic infection,
we collected RNA-seq data from three experimental groups
of mice: uninfected, 10 and 28 days post-infection. Because
T. gondii preferentially establishes cysts in the brains of
mice and reactivation of cysts is the main cause of TE, we
chose to analyze the brains of mice. A novel aspect of this
dataset is that parasites were not purified from the brain
tissue but instead, samples were rapidly processed so that
RNA-seq reads represent the “interactome” between host
and pathogen during the peak of acute and chronic infec-
tion. We report that many genes involved in T. gondii tran-
scription, translation and metabolism are highly expressed
during chronic infection. For the host, we find that more
genes are increased in abundance during chronic versus
(vs) acute infection, attesting to a continuously active host
response even at 28 days post-infection.
Results
Sequencing and mapping the T. gondii/host interactome
To study parasite-host gene expression dynamics we
used RNA-seq on samples collected from forebrains of
mice infected with type II strains of T. gondii (schema-
tized in Figure 1). Type II strains of T. gondii have been
detected in the mouse brain as early as 4 days post-
infection and numbers continue to increase until 10 days
post-infection [23,24], the peak of acute infection [25].
Cyst structures are present in the brains of mice at
21 days post-infection [26], which is generally consid-
ered to be the beginning of chronic infection. By 28 days
post-infection, cysts have stably formed in the brain
while parasite numbers have decreased elsewhere in the
body [23,27]. When brains were sectioned and analyzed
for parasite distribution, high numbers of T. gondii were
observed in the frontal lobe at 32 days post-infection
[22]. We examined mouse brains at 10 and 28 days post-
infection using an In Vivo Imaging System (IVIS), which
confirmed that parasites were primarily localized in the
forebrains of mice (Figure 1). Therefore to maximize
parasite transcripts as well as to compare the same host
tissue during acute and chronic infection, we chose to
collect mouse forebrain samples at 10 and 28 days post-
infection as well as uninfected mice. Nine mouse fore-
brains were sequenced individually: three uninfected,
three infected for ten days and three infected for 28 days.
Nearly one billion 100 base-pair (bp) paired-end RNA
sequences were generated. Between 81,000,000 and
114,000,000 reads were obtained from each forebrain
sample (Table 1). Between 69-76% of the reads aligned to
the M. musculus reference genome while approximately
Uninfected Acute infection Chronic infection 
10 day 28 day 
Forebrains collected, TRIzol  RNA extraction  
Illumina HiSeq200 sequencing: 
950,000,000 Reads 
Alignment to Toxoplasma gondii  and Mus musculus
Normalized reads (FPKM) 
Differential Expression Analysis 




Figure 1 Schematic of T. gondii/host dataset generation. (A) Nine mice were divided into three experimental groups: uninfected, 10 days
post-infection, and 28 days post-infection. Infected mice were given 10,000 type II ME49 parasites and sacrificed on the corresponding days. The
forebrains were removed and homogenized in TRIzol, and RNA was extracted and purified. A cDNA library was generated from the RNA prior to
IlluminaHiSeq2000 sequencing. Raw reads were aligned to either the T. gondii or M. musculus genomes, normalized and analyzed for differential
gene expression. (B) To examine T. gondii in the brains of mice at the designated time points, mice were infected with 10,000 parasites of a
bioluminescent T. gondii [62]. Shown are representative brains for 10 and 28 day post-infection mice, after the brains were soaked for 5 minutes in
luciferin prior to imaging.
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Table 1 Mapped paired-end reads of individual mouse forebrain samples






Uninfected 1 112075860 10752 71901643
Uninfected 2 112948998 7272 72770895
Uninfected 3 103209252 12175 69295619
10 1 102581171 51734 68040784
10 2 125546828 51788 81691030
10 3 81630704 21234 47283570
28 1 103765423 90414 65891584
28 2 113094439 61481 69756643
28 3 114177191 89520 71828085
The first column is the time-point during T. gondii infection for the mouse forebrain samples used for RNA extraction. As three replicates were used for each time
point, the second column is the sample number. The third column is the total number of reads obtained from Illumina HiSeq sequencing. The fourth column is
the total number of paired-end reads from each mouse forebrain sample that mapped to the T. gondii genomic reference file. The fifth column is the total number
of paired-end reads from each experimental group that mapped to the M. musculus genomic reference file.
Table 2 Fold change between chronic and acute infection
for previously characterized T. gondii genes
Gene ID Description Fold change:
chronic/acute
TGME49_316400 α tubulin 0.6
TGME49_209030 actin 1.2
TGME49_289690 GAPDH 1 1.8






First column is the gene number from ToxoDB.org. The middle column is gene
description where α-tubulin, actin, hexokinase, GAPDH-1 and 2 are housekeeping
genes, tachyzoite specific genes are SAG1 and MIC1, and bradyzoite specific
genes are BAG1 and ENO1. The third column is the average FPKM value for
chronic genes divided by the average FPKM value for acute genes.
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T. gondii was not purified from the forebrains as a
means to rapidly process the samples and preserve the
interactome, uninfected mouse forebrain samples were
mapped to the T. gondii TGME49 reference to deter-
mine the extent of false positive reads. A small number
of uninfected mouse reads aligned to the T. gondii gen-
omic reference file (Table 1). The reads aligned to T. gondii
ribosomal associated RNA or small (~200-300 bp) hypo-
thetical proteins, none of which were considered differen-
tially expressed and were treated as background.
Transcript abundance of T. gondii during acute and
chronic infection in mice
Abundance estimates for each T. gondii gene were calcu-
lated and the three biological replicates for each time
point were averaged before differential expression ana-
lysis was performed using Cuffdiff, a Cufflinks program.
Cuffdiff calculates the fold change to determine which
genes are differentially regulated between time points.
Cuffdiff also calculates a p-value and q-value to deter-
mine if the fold change is significant. Each forebrain was
treated as a biological replicate in Cuffdiff and therefore
variation between replicates was considered when assign-
ing a p-value. A p-value and q-value <0.05 were consid-
ered significant. It is important to note that parasites were
not purified from mouse forebrains prior to RNA extrac-
tion. As a result, the concentration of T. gondii RNA could
not be normalized between time points. To address the
potential difference in parasite numbers between experi-
mental time points quantitative PCR was performed using
genomic DNA extracted from the forebrains at the time
of RNA extraction. Using a standard curve generated from
serial dilutions of genomic DNA extracted from a known
number of parasites, we found approximately 500 para-
sites per 350 ng of genomic DNA in 10 day post-infectionsamples and approximately 1500 parasites per 350 ng of
genomic DNA in the forebrains of mice infected for
28 days. These numbers are in agreement with the average
number of reads generated from each time point with ap-
proximately twice as many reads aligning to the T. gondii
genome in the 28 day samples than the 10 day samples
(Table 1). To further examine differences in parasite num-
bers between acute and chronic infection samples, the
FPKM fold change of housekeeping genes α-tubulin,
actin, glyceraldehyde 3-phosphate dehydrogenase 1 and 2
(GAPDH 1 and 2), and hexokinase were examined be-
tween acute and chronic time points (Table 2). The fold
change of these housekeeping genes between chronic and
acute time points were 0.6-1.8, suggesting that global
parasite transcript levels in our acute and chronic infec-
tion samples do not dramatically change.
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terized tachyzoite-specific genes, surface antigen 1 (SAG1)
and microneme protein (MIC) 1, and bradyzoite specific
genes bradyzoite antigen 1 (BAG1) and enolase 1 (ENO1),
we saw large differential expression between acute and
chronic infected mice (Table 2). These results along with
qPCR performed on genomic DNA and quantitation of
the reads that map to the T. gondii genome (Table 1) sug-
gest that the significant differential expression of genes be-
tween time points is not due to an overabundance of
transcripts in chronically infected mice compared to
acutely infected mice. This data is supported in previous
work that determined there is minimal increase in parasite
numbers in the brain between 10 and 20 days [28]. To ac-
count for minimal variability of parasite numbers at
28 days post-infection differentially expressed T. gondii
genes with a fold-change of >5 were considered for further
analysis. The low abundance of SAG-1 and high abun-
dance of BAG-1 between 28 day post-infection and 10 day
post infection time points also suggests that tachyzoites
are the primary stage present at 10 days post-infection,
while the majority of parasites at 28 days post-infection
are in the bradyzoite stage.
To explore the similarities in expression of T. gondii
genes during acute and chronic infection, the 100 most
highly expressed genes from acute and chronic time pointsFigure 2 Top 100 T. gondii genes from acute and chronic infection. (A
FPKM value from acute and chronic time points. Of the top 100 genes for
only abundant in acute (blue) or chronic (yellow) infection. (B) GO terms w
infection. Genes were grouped based on whether they are similar or differewere compared. Forty-two of the most highly expressed
T. gondii genes during the acute stage were also among
the 100 most highly expressed transcripts during the
chronic stage (Figure 2A). To help interpret the biological
functions of these genes, statistically over-represented GO
terms were compiled (Figure 2B) using the Blast2GO pro-
gram, a GO term analysis program for non-model organ-
isms [29]. The GO term categories for the genes with the
greatest abundance in both acute and chronic samples
were transcription, translation, macromolecule biosyn-
thesis and cellular metabolism.
Differential expression of T. gondii between acute and
chronic infection in mice
To further investigate the transcriptome of T. gondii
during acute and chronic infection, differential expres-
sion analysis was performed. Fold change and signifi-
cance values were calculated for each of the ~8900
annotated T. gondii genes (Additional file 1). From this
analysis, we found 547 significantly differentially expressed
genes (DEGs, with p-value and q-value <0.05) between
acute and chronic infection. Of these, the DEGs with a
fold change of >5 are presented in Tables 3 and 4.
Sixty-three T. gondii genes were >5 fold more abun-
dant in acute compared to chronic infection (Table 3).
SAG-related sequence (SRS) are a family of GPI-anchored) Venn diagram compares the 100 T. gondii genes with the greatest
each stage, 42 genes were similarly abundant (green), and 58 were
ere assigned to the top 100 T. gondii genes from acute and chronic
nt between time points prior to GO term analysis.
Table 3 T. gondii DEGs that were more abundant >5-fold
in acute vs chronic infection
Gene ID Description Fold change:
acute/chronic
TGME49_233480 SAG-related sequence SRS29C
(SRS29C)
305
TGME49_233460 SAG-related sequence SRS29B (SAG1) 181
TGME49_291890 microneme protein MIC1 (MIC1) 41
TGME49_241240 hypothetical protein 40
TGME49_224460 aminopeptidase 26
TGME49_262050 rhoptry kinase family protein ROP39 23
TGME49_297880 dense granule protein DG32 19




TGME49_230160 hypothetical protein 12
TGME49_261740 hypothetical protein 12
TGME49_291960 rhoptry kinase family protein ROP40 10
TGME49_268850 enolase 2 9
TGME49_277490 hypothetical protein 9
TGME49_215960 hypothetical protein 9
TGME49_222170 dense-granule antigen DG32 8
TGME49_293430 hypothetical protein 8
TGME49_262730 rhoptry protein ROP16 (ROP16) 8
TGME49_314400 pyruvate dehydrogenase E1
component
8
TGME49_315320 SAG-related sequence SRS52A
(SRS52A)
7
TGME49_200360 hypothetical protein 7
TGME49_285870 SAG-related sequence SRS20A
(SRS20A)
7
TGME49_269950 hypothetical protein 7
TGME49_247280 hypothetical protein 7
TGME49_294800 elongation factor 1-alpha
(EF-1-ALPHA)
7





TGME49_226710 hypothetical protein 6
TGME49_237880 hypothetical protein 6
TGME49_250115 hypothetical protein 6
TGME49_254720 dense granule protein GRA8 (GRA8) 6
TGME49_253930 GCC2 and GCC3 domain-containing
protein
6
TGME49_299780 hypothetical protein 6
TGME49_275860 hypothetical protein 6
TGME49_310780 dense granule protein GRA4 (GRA4) 6
TGME49_277080 microneme protein MIC5 (MIC5) 6
TGME49_226960 phosphofructokinase PFKII (PFKII) 6
Table 3 T. gondii DEGs that were more abundant >5-fold
in acute vs chronic infection (Continued)
TGME49_243730 rhoptry protein ROP9 (ROP9) 6
TGME49_207400 hypothetical protein 6
TGME49_259240 ribosomal protein RPS21 (RPS21) 6
TGME49_205340 ribosomal protein RPS12 (RPS12) 6
TGME49_209150 non-proton pumping type-II
NADH dehydrogenase I (NDH2-I)
6
TGME49_253690 hypothetical protein 5
TGME49_229670 ribosomal protein RPS23 (RPS23) 5
TGME49_244690 hypothetical protein 5




TGME49_251810 translation initiation factor eIF-5A 5
TGME49_200350 subtilisin SUB3 (SUB3) 18*
TGME49_250955 KRUF family protein 21*
TGME49_279350 hypothetical protein 23*
TGME49_313250 hypothetical protein 26*
TGME49_307760 Tubulin-tyrosine ligase family protein 27*
TGME49_315740 SAG-related sequence SRS54 27*
TGME49_243700 hypothetical protein 29*
TGME49_293210 hypothetical protein 30*
TGME49_276110 cytochrome b5 family heme/steroid
binding
34*
TGME49_218740 membrane protein 65*
TGME49_294805 hypothetical protein 77*
TGME49_294990 hypothetical protein 106*
TGME49_216770 hypothetical protein 125*
TGME49_230180 hypothetical protein 129*
TGME49_305050 calmodulin 295*
First column is the gene number from ToxoDB.org. The second column is the
gene description. The far right column is the average FPKM value from acute
infection divided by the average FPKM value from chronic infection, called the
fold change. * in the fold change column indicates the average FPKM value
during chronic infection was 0, and could not be divided by the average FPKM
value in acute samples. A p-value and q-value of <0.05 was considered to be
statistically significant and only genes that met these standards were included
on this table.
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surface antigen, SAG1 [30]. SRS2/SRS29C was the most
differently expressed gene in acute compared to chronic
infection, 305-fold. Five additional SRS genes were >5 fold
more abundant: SRS20A, SAG1/SRS29B, SAG2/SRS34A,
SRS54 and SRS52A. Four genes for rhoptry proteins
(ROP) were >5 fold more abundant during acute infec-
tion: ROP9, ROP16, ROP39, and ROP40. ROP16 is in-
volved in decreased synthesis of cytokines in mouse bone
marrow-derived macrophages [31]. ROP9 is a tachyzoite-
specific protein with no known function [32]. ROP39 and
ROP40 have homology to ROP2, but the functions have
Table 4 T. gondii DEGs that were more abundant >5 fold in
chronic vs acute infection
Gene ID Description Fold change:
chronic/acute
TGME49_224630 zinc finger (CCCH type) protein 86
TGME49_259020 bradyzoite antigen BAG1 (BAG1) 48
TGME49_202020 DnAK-TPR 44
TGME49_278080 Toxoplasma gondii family A protein
(SUSA-1)
32
TGME49_291040 lactate dehydrogenase LDH2 (LDH2) 31
TGME49_200250 microneme protein MIC17A (MIC17A) 29
TGME49_260190 microneme protein MIC13 (MIC13) 29
TGME49_267680 microneme protein MIC12 (MIC12) 28
TGME49_262970 hypothetical protein 26
TGME49_245530 hypothetical protein 26
TGME49_204420 oocyst wall protein OWP1 (OWP1) 23
TGME49_318880 hypothetical protein 18
TGME49_289370 hypothetical protein 18
TGME49_207210 hypothetical protein 18
TGME49_209985 cAMP-dependent protein kinase 18
TGME49_309930 melibiase subfamily protein 17
TGME49_320260 hypothetical protein 15




TGME49_280570 SAG-related sequence SRS35A
(SRS35A)
13
TGME49_320190 SAG-related sequence SRS16B
(SRS16B)
11
TGME49_250940 hypothetical protein 11
TGME49_306620 AP2 domain transcription factor
AP2IX-9 (AP2IX9)
11
TGME49_209755 hypothetical protein 11
TGME49_207160 SAG-related sequence SRS49D
(SRS49D)
10
TGME49_202030 hypothetical protein 10
TGME49_312600 heat shock protein HSP21 (HSP21) 9
TGME49_290000 hypothetical protein 9




TGME49_269670 hypothetical protein 7
TGME49_253330 Rhoptry kinase family protein 7
TGME49_225540 hypothetical protein 7
TGME49_282130 hypothetical protein 6
TGME49_207710 phosphatidylinositol synthase 6
TGME49_205680 hypothetical protein 6
TGME49_276200 hypothetical protein 6
TGME49_283780 6
Table 4 T. gondii DEGs that were more abundant >5 fold in







TGME49_226420 peptidase family M3 protein 6
TGME49_290980 glycine C-acetyltransferase 6
TGME49_275320 penicillin amidase 5
TGME49_201840 aspartyl protease ASP1 (ASP1) 5
TGME49_246080 NAD dependent epimerase/
dehydratase
5
TGME49_222370 SAG-related sequence SRS13 (SRS13) 5
TGME49_315760 AP2 domain transcription factor
AP2XI-4 (AP2XI4)
5
TGME49_294400 hypothetical protein 5
TGME49_215910 hypothetical protein 5
TGME49_224950 calcium-dependent protein kinase
CDPK5 (CDPK5)
5
TGME49_256060 nucleosome assembly protein (nap)
protein
5
TGME49_205750 histone deacetylase complex subunit
Sin3 (SIN3)
5
TGME49_253320 hypothetical protein 15*
TGME49_254330 lipase 16*
TGME49_309790 hypothetical protein 16*
TGME49_269300 lipase 17*
TGME49_223258 hypothetical protein 17*
TGME49_207875 GCC2 and GCC3 domain-containing
protein
17*
TGME49_269020 hypothetical protein 18*
TGME49_261200 TBC domain-containing protein 18*
TGME49_254150 hypothetical protein 18*
TGME49_306500 hypothetical protein 18*
TGME49_245440 hypothetical protein 19*
TGME49_207980 PIG-P protein 19*
TGME49_220150 50S ribosomal protein L16 19*
TGME49_320720 hypothetical protein 19*
TGME49_268765 hypothetical protein 19*
TGME49_260530 Sel1 repeat-containing protein 22*
TGME49_269320 hypothetical protein 23*
TGME49_215300 hypothetical protein 24*
TGME49_308096 rhoptry kinase family protein 25*
TGME49_240470 hypothetical protein 25*
TGME49_460810 ribosomal RNA 25*
TGME49_310045 hypothetical protein 26*
TGME49_224180 hypothetical protein 26*
TGME49_205210 hypothetical protein 26*
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Table 4 T. gondii DEGs that were more abundant >5 fold in
chronic vs acute infection (Continued)




TGME49_215130 adaptor-related protein complex 3 27*
TGME49_207600 tubulin/FtsZ family, GTPase 27*
TGME49_200230 microneme protein MIC17C (MIC17C) 28*
TGME49_231125 hypothetical protein 30*
TGME49_219610 hypothetical protein 31*
TGME49_240480 cpw-wpc domain-containing protein 31*
TGME49_315520 calcium binding egf domain-containing
protein
32*
TGME49_232430 hypothetical protein 33*
TGME49_244412 hypothetical protein 33*
TGME49_223855 RNA recognition motif-containing
protein
35*
TGME49_260325 hypothetical protein 37*
TGME49_234625 EGF family domain-containing
protein
37*
TGME49_255460 hypothetical protein 40*
TGME49_321710 IgA-specific serine endopeptidase 43*
TGME49_319090 proteasome maturation factor
ump1 protein
50*
TGME49_209090 hypothetical protein 52*
TGME49_210682 hypothetical protein 53*
TGME49_213480 hypothetical protein 53*
TGME49_210095 hypothetical protein 57*
TGME49_313890 hypothetical protein 58*
TGME49_271450 hypothetical protein 59*
TGME49_321700 hypothetical protein 80*
TGME49_219742 hypothetical protein 87*
TGME49_266600 Kazal-type serine protease inhibitor 89*
TGME49_257970 hypothetical protein 89*
TGME49_258370 rhoptry kinase family protein ROP28
(ROP28)
103*
TGME49_295662 hypothetical protein 110*
TGME49_278882 GDA1/CD39 (nucleoside phosphatase) 113*
TGME49_264150 hypothetical protein 141*
First column is the gene number from ToxoDB.org. The far right column is the fold
change calculated from the average FPKM value from chronic infection divided by
the average FPKM value from acute infection. * in the fold change column indicates
the average FPKM value during acute infection was 0, and could not be divided by
the average FPKM value in chronic infection. A p-value and q-value of <0.05 was
considered to be statistically significant and only genes that met these
standards were included on this table.
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tachyzoites, most of the DEGs highly abundant in acute
compared to chronic infection (Table 3) have been previ-
ously identified as tachyzoite-specific markers. Twenty-six
of the 63 acute infection DEGs encode hypotheticalproteins, with no homology to any annotated protein in
the BLAST database. Characterizing these hypothetical
proteins could be vital to understanding parasites during
acute infection.
Fifty-one of the 107 T. gondii DEGs associated with
chronic infection with a >5 fold change are annotated
as hypothetical (Table 4). Among the chronic infection
DEGs, four microneme proteins were identified MIC12,
MIC13, MIC17A and MIC17C. MIC12 and MIC13 were
previously shown to be bradyzoite specific [12], but our
data revealed MIC17A and MIC17C abundant specifically
during chronic infection. Another interesting group of
chronic infection DEGs are those involved in glycolysis:
glucose-6-phosphate isomerase, pyruvate kinase, lactate
dehydrogenase 2, and glucosephosphate mutase. Previous
data showed that tachyzoites and bradyzoites use the
glycolytic pathway differently with lactate dehydrogenase
2 and pyruvate kinase being up-regulated during the bra-
dyzoite stage [33,34]. Our data shows that in addition to
these two previously described bradyzoite-specific glyco-
lytic enzymes, glucose-6-phosphate isomerase and gluco-
sephosphate mutase are also more abundant in chronic vs
acute infection. These results strengthen the idea that bra-
dyzoites do not have an active TCA cycle because the
transcripts of the key enzymes in the TCA cycle were less
abundant in chronic infection compared to acute. Four
SRS genes were also identified as more abundant in
chronic compared to acute infection. SRS35A, also known
as SAG4 and P18, is a long-known bradyzoite-specific
marker [35]. SAG2C/SRS49D and SRS9/SRS16B are pre-
viously identified bradyzoite-specific genes that are im-
portant for persistence of infection [36-39]. SRS13 was
identified as up-regulated in a microarray analysis com-
paring tissue culture tachyzoites to mouse-derived brady-
zoites, but the function has yet to be determined [12].
Several novel chronic infection DEGs were found includ-
ing DnAK-TPR, heat-shock protein 21, calcium dependent
protein kinase CDPK5 (Table 4). The high number of
novel and hypothetical DEGs highlights the fact that much
is still unknown about T. gondii during animal infection.
These hypothetical proteins have no known homology to
proteins in the host and therefore could be essential and
specific to parasite function during infection. Identifi-
cation of novel DEGs that could play critical roles in
T. gondii infection is the first step in elucidating poten-
tial targets for both vaccine and drug development.
To highlight the accuracy and sensitivity of RNA-seq,
q-PCR was performed on a family of CCCH zinc fingers
in T. gondii that are more abundant in our data set during
chronic infection. TGME49_224630, TGME49_262970,
and TGME49_311100 contain CCCH zinc finger do-
mains and had a fold change of 86, 26, and 4.7, re-
spectively (Table 4 excluding TGME49_311100 which
did not meet the >5 fold cut-off ). These genes were
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the range of transcript differential expression between
chronic and acute infection. The increase in abun-
dance of these transcripts between 10 day and 28 day
post-infection was observed using qPCR when normal-
ized to the house keeping gene tub1a. The fold change
between chronic and acute infection for TGME49_224630,
TGME49_262970, and TGME49_311100 were 53, 79, and
6.1 respectively. Not only does this data demonstrate the
range and accuracy of RNA-seq, but also confirms the val-
idity of the differential expression analysis.
Differential expression of host genes during T. gondii
infection
To understand the transcriptional changes of the host
during stages of T. gondii infection, differential expres-
sion analysis was conducted. Differential expression was
determined between acute vs uninfected, chronic vs un-
infected, and acute vs chronic time points. Genes were
considered differentially expressed if the p-value and
q-value was <0.05 and the fold change between time
points was >2-fold. The host underwent extensive tran-
scriptional changes during T. gondii infection (Figure 3A).
When comparing acute T. gondii infected mice with unin-
fected, 1004 mouse genes were more abundant during
acute infection and 143 were less abundant (Figure 3A).
Over twice as many mouse genes, 2510, were more abun-
dant in mice with a chronic T. gondii infection compared
to uninfected while only 132 genes were less abundant. Fi-
nally, 1872 mouse genes were more abundant and 190
were less abundant in chronically vs. acutely infected
mice. This increase of differentially regulated host genes
during chronic infection is illustrated by Venn diagram
analysis of DEGs >2-fold (Figure 3B). To understand the
similarities and differences between DEGs more abundant
during acute vs uninfected and chronic vs uninfected time
points, we identified genes that had increased abundance
at both time points as well as those found only in acute or
chronic (Additional files 2, 3 and 4). Out of the 1004 DEGs
more abundant in acute vs uninfected, 902 were also abun-
dant in the chronic vs uninfected group. More mouse genes,
1608, were increased in abundance in the chronic vs unin-
fected time point that were not considered differentially
expressed in acute. This data suggests genes activated during
the peak of acute infection are maintained during chronic
infection and that an entirely new subset of transcripts are
expressed during chronic infection. The increase in differen-
tially expressed genes during chronic infection could also be
due to recruitment of cells to the site of infection.
GO term enrichment analysis of DEGs in mice during T. gondii
infection
To understand the functions of DEGs in mice during
acute and chronic T. gondii infection and to characterizethe overlap between DEGs at these time points (Figure 3B)
we performed GO term enrichment analyses. Among the
host genes more abundant during both acute and chronic
infection stages, overrepresented GO terms were related
to stress and immune responses (Figure 3C). This suggests
infection with T. gondii stimulates the immune response
and/or immune cell recruitment into the brain even when
the majority of parasites are in the encysted stage, as seen
by the increased abundance of BAG1 and decreased abun-
dance of SAG1 (Table 2). It also suggests a specific subset
of host genes are responsible for immune stimulation dur-
ing chronic infection that are distinct from acute, although
many acute infection associated genes are still activated.
Only a small number of host DEGs were less abundant
during both acute and chronic infection (Figure 4A). Go
term analysis of DEGs with decreased abundance showed
little functional overlap between the different stages of in-
fection. The few commonalities in GO categories included
secondary metabolism, membrane organization and phago-
cytosis (Figure 4B). The proposed functions of the DEGs
that were less abundant specifically during acute infection
were different from those less abundant during chronic in-
fection. GO terms for genes with decreased abundance spe-
cifically during acute infection were proteolysis, protein
metabolic process, and anatomical structure, while GO
terms specific to chronic infection were cell-cell communi-
cation and primary metabolic function. The enrichment
of metabolism-associated processes among less abun-
dant DEGs suggests a link between T. gondii infection
and host metabolism, possibly as a means of restricting
parasite growth.
Analysis of the mouse genes with increased abundance
during T. gondii infection
Given that more host transcripts had >2-fold increased
abundance during chronic infection (Figure 3B), further
examination of the most abundant mouse genes during
acute and chronic time points was performed to en-
hance the understanding of the host response. DEGs
with a FPKM fold change >20 were compared between
acute vs uninfected and chronic vs uninfected mice
(Figure 5A). 155 genes met this cut-off in the acute vs
uninfected group while 540 genes had 20-fold or higher
FPKM values in chronic vs uninfected time points. Of
these more abundant DEGs, 146 were shared between
acute vs uninfected and chronic vs uninfected groups.
Only 9 more abundant DEGs had a fold change >20 in
acute vs uninfected that were not highly abundant in
chronic vs uninfected time points. Several of these acute-
infection specific host genes belong to the family of
guanylate-binding proteins, which are GTPases that are
induced by interferon-γ (Table 5). Conversely, 394 DEGs
had a fold change of >20 in chronic vs uninfected that did
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Figure 3 More host genes have increased abundance during chronic infection. (A) DEGs in the mouse with a fold change >2 were
grouped based on increased abundance (grey) and decreased abundance (black) between acute vs uninfected, chronic vs uninfected, and
chronic vs acute time points. (B) A Venn diagram was created to compare DEGs with increased abundance in acute vs uninfected (purple) and
chronic vs uninfected time points (red). Of the 1004 more abundant DEGs in acute vs uninfected, 902 were also more abundant in the chronic vs
uninfected group (magenta). (C) To explore the function of DEGs analyzed in the Venn diagram, a GO term enrichment analysis was performed.
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are maintained into chronic infection. These results show
that few host genes are specifically increased during acute
T. gondii infection. It also suggests a unique set of host
genes are differentially expressed during chronic infection.
Elevation of immune response genes during chronic infection
To assess the function of the mouse genes increased in
abundance specifically during chronic infection, GO termFigure 4 Analysis of host genes with decreased abundance during T.
>2-fold decreased abundance in acute vs uninfected (purple) and chronic
both acute and chronic infection (magenta). (B) To explore the function of
was performed. Functionally enriched GO terms display little similarity betwenrichment was performed on genes with a fold change
>20 in chronic vs acute infection. GO terms for genes
highly increased in abundance during chronic infection
were related to stress and immune responses (Figure 5B).
Table 6 shows the top 50 DEGs more abundant during
chronic infection. Many of these genes are immunoglobu-
lin heavy chain variable regions, which share sequence
similarity and can be difficult to differentiate between.
The variable regions of immunoglobulins are responsiblegondii infection. (A) A Venn diagram was created to compare DEGs
vs uninfected (red) mice. Forty host genes were less abundant during
DEGs analyzed in the Venn diagram, a GO term enrichment analysis
een time points.
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Figure 5 Few highly expressed DEGs are specific to acute infection. (A) To better characterize abundant DEGs, a Venn diagram of the more
abundant DEGs in the mouse with a fold change >20 between acute vs uninfected (purple) and chronic vs uninfected (red) time points. Of these
more abundant DEGs, 146 were shared between acute and chronic infection (magenta). Only 9 DEGs had a fold change >20 in acute vs
uninfected that were also not highly abundant in chronic vs uninfected time points. (B) To analyze the function of the host more abundant DEGs
in chronic vs acute time points, GO term enrichment analysis was performed. Many genes differentially expressed in chronic infection are
associated with immune regulation and stress response.
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ent subset of antibodies being produced in response to
T. gondii antigens that may not be abundant during
acute infection. Another highly differentially expressed
set of genes are H2-EB2 and H2-M2, both of which are
involved in antigen presentation. H2-EB2 is an MHC
class I membrane-associated protein while H2-M2 is
an MHC class II membrane-associated protein. These
antigen-presenting proteins are key players in the con-
tinued stimulation of the immune system at later time
points. This increased in abundance of immune genes
during chronic infection indicates a unique set of DEGs
may be involved in the chronic infection immune responseand/or a novel population of immune cells are recruited
into the brain after acute infection.
Discussion
Infection with T. gondii is often asymptomatic in im-
mune competent individuals, but presents serious health
risks if acquired congenitally or if a person becomes
immune-compromised. Rising evidence is showing com-
plications, such as psychiatric disorders and increased
rates of suicide, occur in people with healthy immune
systems who have a chronic T. gondii infection [40,41].
Currently, drug treatment is only effective against the
acute stage of infection and there are no therapeutics
Table 5 Mouse DEGs more abundant in acute, but not chronic infection
Gene ID Gene name Description Fold change (Acute/uninfected) Fold change (Chronic/uninfected)
ENSMUSG00000088071 Gm22818 predicted gene, 22818 276 1
ENSMUSG00000002831 Gbp10 guanylate-binding protein 10 183 No transcripts in Chronic
ENSMUSG00000002833 Gbp6 guanylate binding protein 6 130 No transcripts in Chronic
ENSMUSG00000024334 Gbp4* guanylate binding protein 4 61 No transcripts in Chronic
ENSMUSG00000075010 Gbp8* guanylate-binding protein 9 61 No transcripts in Chronic
ENSMUSG00000085377 Gbp9* guanylate-binding protein 8 61 No transcripts in Chronic
ENSMUSG00000098049 BC042782# cDNA sequence BC042782 52 1.8
ENSMUSG00000079362 n-R5s189# nuclear encoded rRNA 5S 189 52 1.8
ENSMUSG00000005800 Plin4 perilipin 4 27 1
The first column is the ensemble gene ID and the second is the gene name. The third column is the official gene symbol from ensemble.org, and the fourth
column is the fold change as average acute FPKM value was divided by uninfected. The fifth column is the fold change as average chronic FPKM value was
divided by uninfected. Only genes with a p-value and q-value <0.05 were considered differentially expressed. * and # mark genes located in the same contiguous
loci and thus reads mapping to this area were combined.
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ing chronic infection. There are also no vaccines
against T. gondii approved for use in humans. This
lack of therapeutic intervention highlights the need to
better understand the biological differences between the
acute rapidly replicating form of the parasite and the
chronic associated cyst stage.
Our data provides a list of candidate genes that could
be targeted for novel therapeutics or gene deletion to
create a non-persistent vaccine strain (Tables 3 and 4).
Many of these genes highly differentially regulated are
hypothetical proteins with no known orthologs in other
organisms. Hypothetical T. gondii genes not found in
the mammalian host could be excellent pathogen spe-
cific drug targets. The fact that multiple T. gondii micro-
neme proteins are more abundant in chronic infection
stages raises the question of whether parasites during
chronic infection are actively invading cells. If parasites
are invading at this time, this could explain the contin-
ued stimulation of the host response so late in infection.
Although microarray analysis of human fibroblasts showed
that tissue culture derived bradyzoites stimulated a weaker
immune response than tachyzoites after two days [42]. An
additional T. gondii gene that is more abundant in
chronic infection is cAMP-dependent protein kinase.
cAMP-dependent protein kinase is crucial for growth
of tachyzoites and is proposed to be critical in tachy-
zoite to bradyzoite stage conversion[43,44], but the
mechanism is unknown. Another potentially interest-
ing T. gondii gene that is more abundant in chronic in-
fection is calcium dependent protein kinase 5, CDPK5.
The T. gondii paralog, TgCDPK1, was shown to be ne-
cessary for tachyzoite motility, invasion and egress [45].
Studying the role of CDPK5 in bradyzoite development
could be pivotal in understanding the biology of this
stage.Our study also provides crucial insight into host re-
sponse to the parasite during both acute and chronic in-
fection. It shows that, at least in the beginning stages of
chronic infection, the host immune system is still ac-
tively combating infection. Chronic infection of T. gondii
is typically thought of as a period in which the parasite
transitions to the encysted, less immune stimulatory
form resulting in a dampening of the immune response.
Another study assessing the mouse transcriptome showed
many immune associated genes are still expressed at
32 days post T. gondii infection [22]. To assess the over-
arching function of genes increased in abundance between
acute and chronic infection Kyoto Encyclopedia of Genes
and Genomes (KEGG) pathway analysis was performed
(Additional file 5). The KEGG database is a bioinformatics
tool that assembles large-scale molecular datasets, such as
gene lists, into biological pathway maps (example
Additional file 6). Analysis of our dataset suggests active
NK cells are recruited to the brain during chronic infec-
tion by the increased abundance of perforin, granzymes A
and B, and IL-10 (additional files 3 and 4). NK cells have
long been known to be essential for the control of acute
T. gondii infection [46], but their role in chronic infec-
tion maintenance has yet to be elucidated. NK cells are
a significant source of IFN-γ during acute T. gondii in-
fection [47,48] and IFN-γ is also necessary to maintain
chronic infection [49], but producers of IFN-γ during
chronic infection have not been determined. In mice
with an established chronic T. gondii infection, NK
cells are a major source of IFN-γ essential to combat in-
fection with H5N1 influenza virus [50]. Chronic T. gondii
infection was equally effective to protect against lethal in-
fluenza virus whether the mice had been infected with
T. gondii for 1 month or 4 months, suggesting that NK
cells are active in late stages of chronic infection. Simi-
larly, NK are elicited in peritoneal exudate 6 months after
Table 6 The top 50 mouse DEGs more abundant in chronic vs. acute infection
Gene ID Description Gene symbol Fold change (chronic vs acute)
ENSMUSG00000076652 immunoglobulin heavy variable 7-3 Ighv7-3 672*
ENSMUSG00000076653 immunoglobulin heavy variable 7-2 Ighv7-2 672*
ENSMUSG00000095571 immunoglobulin heavy variable 5-17 Ighv5-17 672*
ENSMUSG00000076564 immunoglobulin kappa chain variable 12-46 Igkv12-46 656*
ENSMUSG00000096422 immunoglobulin kappa variable 12-44 Igkv12-44 656*
ENSMUSG00000076604 immunoglobulin kappa joining 1 Igkj1 353*
ENSMUSG00000076605 immunoglobulin kappa joining 2 Igkj2 353*
ENSMUSG00000076607 immunoglobulin kappa joining 4 Igkj4 353*
ENSMUSG00000076608 immunoglobulin kappa joining 5 Igkj5 353*
ENSMUSG00000076612 immunoglobulin heavy constant gamma 2C Ighg2c 23*
ENSMUSG00000076617 immunoglobulin heavy constant Ighm 23*
ENSMUSG00000076618 immunoglobulin heavy joining 4 Ighj4 23*
ENSMUSG00000076619 immunoglobulin heavy joining 3 Ighj3 23*
ENSMUSG00000076621 immunoglobulin heavy joining 1 Ighj1 23*
ENSMUSG00000094028 immunoglobulin heavy diversity 4-1 Ighd4-1 23*
ENSMUSG00000095079 immunoglobulin heavy constant alpha Igha 23*
ENSMUSG00000095007 immunoglobulin kappa chain variable 12-41 Igkv12-41 356
ENSMUSG00000076609 immunoglobulin kappa chain, constant region Igkc 353
ENSMUSG00000016283 histocompatibility 2, M region locus 2 H2-M2 111
ENSMUSG00000002992 apolipoprotein C-II Apoc2 70
ENSMUSG00000074336 apolipoprotein C-IV Apoc4 70
ENSMUSG00000019987 arginase, liver Arg1 69
ENSMUSG00000071716 apolipoprotein L 7e Apol7e 60
ENSMUSG00000058216 cDNA sequence BC021614 BC021614 45
ENSMUSG00000042262 chemokine (C-C motif) receptor 8 Ccr8 44
ENSMUSG00000014453 B lymphoid kinase Blk 38
ENSMUSG00000050063 kallikrein related-peptidase 6 Klk6 38
ENSMUSG00000082976 predicted gene 15056; similar to beta-defensin 52 Gm15056 38
ENSMUSG00000053977 CD8 antigen, alpha chain Cd8a 37
ENSMUSG00000030577 CD22 antigen; hypothetical protein LOC100047973 Cd22 36
ENSMUSG00000020017 histidine ammonia lyase Hal 35
ENSMUSG00000027863 CD2 antigen Cd2 35
ENSMUSG00000067149 immunoglobulin joining chain Igj 35
ENSMUSG00000030724 CD19 antigen Cd19 34
ENSMUSG00000067341 histocompatibility 2, class II antigen E beta2 H2-Eb2 34
ENSMUSG00000068129 cystatin F (leukocystatin) Cst7 33
ENSMUSG00000079293 C-type lectin domain family 7, member a Clec7a 32
ENSMUSG00000096594 immunoglobulin kappa variable 8-19 Igkv8-19 32
ENSMUSG00000002033 CD3 antigen, gamma polypeptide Cd3g 31
ENSMUSG00000050232 chemokine (C-X-C motif) receptor 3 Cxcr3 28
ENSMUSG00000053044 CD8 antigen, beta chain 1 Cd8b1 28
ENSMUSG00000054672 RIKEN cDNA 5830411 N06 gene 5830411N06Rik 28
ENSMUSG00000094738 predicted gene, 26177 Gm26177 28
ENSMUSG00000005947 integrin alpha E, epithelial-associated Itgae 27
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Table 6 The top 50 mouse DEGs more abundant in chronic vs. acute infection (Continued)
ENSMUSG00000022657 CD96 antigen Cd96 27
ENSMUSG00000024669 CD5 antigen Cd5 27
ENSMUSG00000024910 cathepsin W Ctsw 27
ENSMUSG00000031933 folate receptor 4 (delta) Folr4 27
ENSMUSG00000026070 interleukin 18 receptor 1 Il18r1 26
ENSMUSG00000035042 chemokine (C-C motif) ligand 5 Ccl5 25
The first column is the ensemble gene ID and the second is the gene name. The third column is the official gene symbol from ensemble.org, and the fourth
column is the fold change as average chronic FPKM value was divided by acute. Only genes with a p-value and q-value <0.05 were considered differentially
expressed. * in the fold change column indicates the average FPKM value during acute infection was 0, and could not be divided by the average FPKM value in
chronic infection.
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play a role in chronic T. gondii infection maintenance,
which will be the focus of future studies in understanding
infection persistence.
Production of nitric oxide (NO) is crucial for control
of T. gondii growth [52,53], and triggers differentiation
of tachyzoites into bradyzoites in tissue culture [54].
Mice deficient in the inducible nitric oxide synthetase
gene succumb to non-lethal doses of T. gondii, but only
during chronic infection [52,53]. One host gene differen-
tially expressed during chronic infection is arginase-1
(ARG-1), which had a fold change of nearly 70 in chronic
vs. acute samples (Table 6). Arginine is not only a sub-
strate for NO production, but it is an essential amino acid
for T. gondii [55]. ARG-1 depletes host cell arginine, pos-
sibly as means to starve the parasite, but in type I strains,
T. gondii initiates expression of ARG-1 via ROP16, poten-
tially to preserve infected tissue [31]. While NO is detri-
mental for parasite growth, it also results in inflammation
and subsequent destruction of host tissue. In the brain,
microglial cells are the main producers of NO and have
the potential to cause neuronal degradation. T. gondii-in-
fected astrocytes secrete factors that decrease NO produc-
tion by microglial cells, thus preserving both host and
pathogen during latent infection [56]. It is unclear whether
the increase in ARG-1 transcripts is induced by T. gondii
or the host as ROP16 is more abundant in T. gondii dur-
ing acute infection (Table 3), and ARG-1 is more abun-
dant in the host during chronic infection. Furthermore,
ROP16 is polymorphic and in type II strains, such as
ME49 used in this study, does not maintain STAT3/6 acti-
vation and may not initiate ARG-1 expression [57]. An al-
ternative mechanism may be responsible for the increased
abundance of ARG-1 during chronic infection. Another
highly differentiated host genes during chronic infection is
kallikrein-6 peptidase. Kallikrein peptidases have been im-
plicated in infection through involvement in vasodilation
and permeability [58], but in the context of bacterial infec-
tions, kallikreins are also involved in the generation of NO
[58,59]. Specifically, kallikrein-6 has been shown to be up-
regulated in the CNS during inflammation, possibly as a
means to promote lymphocyte survival [60,61]. Ourdata suggest kallikrein proteases could be involved in
the parasite’s transition from the rapidly replicating
form to the encysted form in the host. Together these
data suggest that regulation of NO production during
chronic infection is of vital importance for both the host
and the parasites, and will be a future avenue of research.
Conclusions
The depth of RNA-seq coverage allowed, for the first
time, simultaneous sampling of both host and microbe
during acute and chronic stages of animal infection. In this
study, we show the majority of highly expressed T. gondii
genes common to both acute and chronic infection are in-
volved in transcription and translation, underscoring that
parasites in both stages are actively synthesizing proteins.
Similarly, most of the T. gondii genes highly expressed
during chronic infection are involved in metabolism,
highlighting the metabolic activity of the cyst at 28 days
post-infection. For the host, analysis of transcripts at 10
and 28 days post-infection compared to uninfected mice
showed that more immunity associated host genes are in-
creased in abundance at 28 days post-infection vs 10 days
post-infection. The increase in abundance of T. gondii
genes during chronic infection is in conjunction with the
heightened host response; indicative of the constant battle
for survival between the host and the parasite. Discussed
here are only a few examples of hypotheses that can be
generated from this transcriptome data set. This dataset is
novel because information from the host and pathogen is
provided at multiple time points, allowing for the interplay
between both to be studied. Many platforms, such as
KEGG pathways and DAVID, are available for the research
community to further investigate these data and cater to
their scientific interests. This data provides the potential to
elucidate mechanisms required for Apicomplexan parasites
to maintain a relationship with their hosts, which will lead
to better therapeutics, vaccines and diagnostic methods.
Methods
Ethics statement
Animals were housed under conventional, specific-
pathogen-free conditions and were treated in compliance
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Use Committee of the University of Wisconsin School of
Medicine and Public Health (IACUC), according to
IACUC approved protocol number M01545. This proto-
col adheres to the regulations and guidelines set by the
National Research Council. The University of Wisconsin
is accredited by the International Association for Assess-
ment and Accreditation of Laboratory Animal Care.
IVIS detection of T. gondii in the mouse forebrain at
10 days and 28 days post-infection
The ME49 strain of T. gondii with a deletion of the gene
HPT and an insertion of the coding region for firefly lu-
ciferase, as previously described [62], was used for these
experiments. 6–8 week old BALB/C mice (National Can-
cer Institute, Charles River Laboratories, Frederick, MD)
received an intraperitoneal (i.p.) inoculation of 104
freshly lysed tachyzoites. Mice were imaged using IVIS
(PerkinElmer) at 10 days and 28 days post-infection. Mice
were anesthetized with isoflurane and intravenous (i.v.)
injected with 3 mg of luciferin, the substrate for luciferase,
and imaged ventrally, dorsally, and then sacrificed. The
brains of the mice were removed and soaked in luciferin
for 5 minutes prior to imaging.
Generation of mRNA and RNA-seq
A ME49 strain of T. gondii that was recently passaged
through the sexual cycle was used to inoculate mice for
RNA-seq analysis. ME49 was maintained as tachyzoites
in monolayers of Human Foreskin Fibroblasts in Dulbecco’s
Modified Eagle’s Medium supplemented with 10% FBS,
2 mM L-glutamine, and 1% penicillin-streptomycin. 6–8
week old CBA/J mice (National Cancer Institute, Charles
River Laboratories, Frederick, MD) were either left unin-
fected or i.p. injected with 104 parasites and were sacrificed
at 10 days and 28 days post-infection. Uninfected mice were
sacrificed along with the 28 day post-infection group. We
selected T. gondii infected mice that were healthy and not
displaying any signs of disease, so samples would not con-
tain host transcripts involved with inappetence, dehydration
or general malaise to confound our analyses. To minimize
changes to the transcriptome, the forebrains were rapidly
and precisely sectioned at the intersection of the optic
nerves using a mouse brain matrix (Zivic Instruments) with
less than one minute between animal sacrifice to forebrain
homogenization in 3 mL of TRIzol. Total RNA was isolated
according to manufacturer’s protocol. RNA was purified
using Promega SV total RNA isolation system according to
manufacturer’s protocol. RNA was submitted to the Univer-
sity of Wisconsin Biotechnology Center for purity analysis
using the Agilent 2100 Bioanalyzer and sequencing using
the Illumina HiSeq2000. Sequencing was performed on each
individual mouse and samples were not pooled. Infection
was quantified in the un-used hindbrains collected at 28 dayspost-infection and stained with fluorescein labeled Dolichos
biflorus agglutinin (Vector Laboratories) for cyst detection.
All 28 day post-infection hindbrains contained a minimum
of 10,000 cysts.
Determination of T. gondii parasite numbers in mouse
forebrain samples
Genomic DNA was extracted from each mouse fore-
brain at the time of RNA extraction using TRIzol ac-
cording to manufactures instructions. DNA was purified
by phenol/chloroform extraction followed by ethanol
precipitation. Genomic DNA was used as the template
for quantitative PCR using T. gondii primers for the
housekeeping gene alpha-tubulin (TUB1A). Tub1A For-
ward primer 5’-GACGACGCCTTCAACACCTTCTTT-3’,
Tub1A Rev 5’-AGTTGTTCGCAGCATCCTCTTTCC-3’.
Primer efficiency for TUB1A was 2.002 with an R2 value
of .99 using T. gondii genomic DNA. To determine para-
site burden in the mouse forebrain samples, a standard
curve was generated using a genomic DNA preparation of
known parasite numbers. Quantitative PCR was per-
formed on serial dilutions of parasite genomic DNA, using
TUB1A primers, ranging from 10 to 1×106 parasites. A
best-fit logarithmic line was generated with an R2 of 0.999.
The equation of the line along with Ct values obtained
from qPCR of TUB1A on genomic DNA from each fore-
brain sample was used to extrapolate parasite numbers.
qPCR was performed on each sample in duplicate using
BIO-RAD iTaq Universal SYBR Green Supermix product
number 172–5121.
Quantitative PCR of T. gondii CCCH zinc fingers
Sequences for TGME49_224630, TGME49_269270, and
TGME49_311100 were obtained from ToxoDB.org. Se-
quences were run through BLASTp to confirm presence
of CCCH zinc finger motifs. cDNA was generated from
the same RNA samples used for RNA sequencing with
Invitrogen Superscript III Reverse Transcriptase cDNA
synthesis kit. All CCCH zinc fingers were normalized to
the T. gondii house keeping gene tub1A. Efficiencies
were determined using in vitro bradyzoite cDNA. RNA
was extracted from 5 day bradyzoites grown under low
CO2 and high pH conditions using TRIzol. cDNA was
generated using the Invitrogen Superscript III Reverse
Transcriptase cDNA synthesis kit. Efficiencies were cal-
culated using the slopes of a 1:10 dilution series (neat
through 104) and the formula E = 10[−1/slope]. Efficiencies
for tub1A, TGME49_224630, TGME49_269270, and
TGME49_311100 were 1.96, 1.89, 2.14, and 2.04 (Be-
tween 95-107% efficient). Quantitative PCR was performed
using Bio-Rad iTaq Universal SYBR Green Supermix on an
Applied Biosystems StepOnePlus Real-Time PCR system.
Primers were used at a 300 nM concentration and an exten-
sion temperature of 60°C for 60 seconds for all primer
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for 60 seconds. Relative quantification was calculated
using Pfaffl’s method [63]. The three biological repli-
cates were used and conducted in duplicate. Wells
with only one melt curve and temperature were used,
and duplicate Ct values were all at or below a 0.25 dif-
ference in cycle threshold value. Primers: Tub1A, same




TGME49_269270 Forward 5’- GCTTACCGAGGATG
ACCTGCT-3’
Reverse 5’-CCGTACACTGGTGGCGATCAT-3’
TGME49_311100 Forward 5’- TTTGCCCACACAGC
CGAAGAA-3’
Reverse 5’- GCCACAGATGCCTTCCGTAAC-3’.RNA-seq, mapping and differential expression analysis
Approximately 950,000,000 paired end 100 bp reads
were generated from Illumina HiSeq2000 sequencing.
Aligning RNA-seq data for eukaryotic organisms be-
comes difficult when mapping to a genomic reference
because of the presence of introns in the reference and
polyadenylated transcripts in the data. If an RNA-seq
read spans an exon-exon junction or a polyadenylated
region of a transcript it will be “unmappable” to the
reference genome and is discarded. Bioinformatics soft-
ware, such as TopHat, has been created to consider exon-
exon boundaries during the mapping process [64]. Raw
reads were uploaded onto the Galaxy platform [65-67].
Reads were filtered by Sanger quality score using FASTQ
Groomer v. 1.0.4 and paired end reads were aligned against
the genomes of T. gondii (TGME49 version 9.0; ToxoDB.
org) and M. musculus (GRCm38 version 74.38; ensemble.
org/Mus_musculus) references uploaded into Galaxy using
TopHat2 [68]. Parameters for TopHat2: Max edit distance
of 2, final read mismatch of 2, anchor length of 8, mini-
mum intron length of 70, maximum intron length of
500000, max insertion and deletion length of 3, number of
mismatches allowed of 2, and a minimum length of read
segments of 25. Reads were not treated as strand specific
as they were paired end reads. The total numbers of reads
were as followed: Uninfected mouse 1 was 112075860, Un-
infected mouse 2 was 112948998, Uninfected mouse 3 was
103209252, 10 day post-infection mouse 1 was 102581171,
10 day post-infection mouse 2 was 125546828, 10 day
post-infection mouse 3 was 81630704, 28 day post-
infection mouse 1 was 103765423, 28 day post-infection
mouse 2 was 113094439, and 28 day post-infection mouse
3 was 114177191. The number of reads that mapped to
the T. gondii genomic reference file and M. musculus gen-
omic reference files are listed in Table 1.The program Cufflinks [64] was used to convert aligned
reads of BAM files, generated from Tophat2, into relative
expression values for each gene represented as FPKM
(fragments per kilobase of exon per million mapped
reads). Cuffdiff was used to detect significant changes in
differential expression between the experimental groups.
When running Cuffdiff, a GTF file obtained from Tox-
oDB.org and ensemble.org/Mus_musculus was used as
a guide and the TopHat2 aligned BAM files from each
biological replicate were used as the source of com-
parison between experimental groups. A geometric li-
brary normalization and a pooled cross-replicate dispersion
estimation method was used when comparing differential
expression between each experimental group. Genes with a
p-value, for statistical significance, and q-value, to detect the
false discovery rate, of <0.05 were considered differentially
expressed. The “gene differential testing” output file from
Cuffdiff was used to identify differentially expressed genes.
GO term analysis
FASTA sequences of the most abundant T. gondii genes
from different time points during infection were loaded
into the program Blast2Go [29]. T. gondii is not an avail-
able organism on many GO term analysis programs, mak-
ing Blast2Go ideal for uncommon models. Sequences
were run with the blastx program against the nr database.
Aligned sequences were mapped and assigned GO term
annotations. Combined graphs were generated represent-
ing the most enriched GO terms in the provided gene
list. A score was assigned to determine significance of
enrichment. For analysis of M. musculus, a gene list was
generated from each experimental time point based on
gene names in column C of Additional files 2, 3, and 4.
Ensembl gene IDs were obtained from these gene names,
exported from BioMart and uploaded to the functional an-
notation tool. A functional annotation chart of the enriched
GO terms was generated using GO terms associated with
biological process. GO terms were assigned a p-value to in-
dicate significance of enrichment [69]. Only GO terms with
a p-value <0.05 were used to represent functional enrich-
ment. For further analysis of M. musculus, the online
Database for Annotation, Visualization, and Integrated
Discovery (DAVID) was used (david.abcc.ncifcrf.gov).
Availability
Raw short read RNA-seq data has been submitted to
ToxoDB and to NCBI with SRA: SRS550800, http://
www.ncbi.nlm.nih.gov/biosample/2615816.
Additional files
Additional file 1: Differential expression analysis of T. gondii genes
between acute and chronic time points generated by Cuffdiff.
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http://www.biomedcentral.com/1471-2164/15/806Additional file 2: Differential expression analysis of M. musculus
genes between acute vs. uninfected time points generated by
Cuffdiff.
Additional file 3: Differential expression analysis of M. musculus
genes between chronic vs. uninfected time points generated by
Cuffdiff.
Additional file 4: Differential expression analysis of M. musculus
genes chronic divided by acute time points generated by Cuffdiff.
Additional file 5: Top 5 significant KEGG pathways during chronic
vs acute infection. Genes with a >2 fold abundance between chronic
and acute infection were uploaded to the KEGG pathway database.
Displayed above are the most 5 most significant pathways enriched
during chronic infection. The first column is the KEGG pathway
description. Second column is the number of genes that fall into each
category. The third column is the p-value designating the significance of
each category.
Additional file 6: NK cell mediated cytotoxicity KEGG pathway.
Schematic representation of NK cell mediated cytotoxicity provided by
Kyoto Encyclopedia of Genes and Genomes (http://www.genome.jp/
kegg/). Red stars indicate genes that are more abundant between
chronic and acute infection in the mouse forebrain. For description of
features on the map visit http://www.genome.jp/kegg/document/
help_pathway.html.
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